Showing posts with label advanced cutaneous T-cell lymphoma (CTCL) and in elderly patients with acute myeloid leukemias (AML).. Show all posts
Showing posts with label advanced cutaneous T-cell lymphoma (CTCL) and in elderly patients with acute myeloid leukemias (AML).. Show all posts
Wednesday, July 25, 2012

Cyclacel Presents New Phase 2 Data of Sapacitabine for MDS

›
We know that, Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA sy...